When evaluating a new treatment, the control group is the benchmark. But not all control arms are created equal. This article explores two common approaches: contemporary observational arms and historical control groups.
Contemporary observational arms avoid biases that arise from changes in medical practice over time. However, they lack random allocation, which can introduce selection bias. In contrast, historical control groups can draw on vast datasets, but they are vulnerable to shifting standards of care, meaning that what was standard five years ago may no longer be relevant.
Understanding these trade-offs is essential for interpreting modern medical research. The choice of control arm can significantly influence study conclusions and, ultimately, patient care.